Mycophenolate mofetil

Mycophenolate mofetil is an immunosuppressive medication that is used to prevent organ rejection in patients who have undergone a transplant. It works by inhibiting the activity of certain white blood cells, specifically T-cells, which play a key role in the body’s immune response. By suppressing the immune system, mycophenolate mofetil helps to reduce the risk of the body rejecting the transplanted organ.
Mycophenolate mofetil is often prescribed for patients who have received a kidney, heart, liver, or bone marrow transplant. It is typically used in combination with other immunosuppressive medications to ensure the most effective protection against organ rejection.
Mycophenolate mofetil is available in tablet and capsule forms, and it is usually taken twice a day. The dosage and duration of treatment will depend on the patient’s specific condition and the type of transplant they have received.
It is important for patients to follow their healthcare provider’s instructions carefully and to report any side effects or concerns promptly. Mycophenolate mofetil can cause side effects such as nausea, vomiting, diarrhea, and an increased risk of infections. Patients should also avoid becoming pregnant while taking this medication, as it can cause harm to a developing fetus.